143 related articles for article (PubMed ID: 8656505)
1. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study.
Bristow CC; Larson E; Anderson LJ; Klausner JD
Sex Transm Infect; 2016 Aug; 92(5):340-6. PubMed ID: 26920867
[TBL] [Abstract][Full Text] [Related]
3. The effect of prophylaxis on pediatric HIV costs.
Wilson LS; Hensic L; Paoli CJ; Basu R; Christenson M; Moskowitz JT; Wara D
AIDS Care; 2012; 24(1):108-18. PubMed ID: 21780991
[TBL] [Abstract][Full Text] [Related]
4. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.
Udeh B; Udeh C; Graves N
BMC Infect Dis; 2008 Dec; 8():174. PubMed ID: 19117527
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.
Ruger JP; Lazar CM
Addict Behav; 2012 Jan; 37(1):1-10. PubMed ID: 21962429
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of voluntary HIV screening in Russia.
Tole SP; Sanders GD; Bayoumi AM; Galvin CM; Vinichenko TN; Brandeau ML; Owens DK
Int J STD AIDS; 2009 Jan; 20(1):46-51. PubMed ID: 19103893
[TBL] [Abstract][Full Text] [Related]
7. [Codevelopment and health. Prevention of HIV transmission in Ghana: the Brothers in Work Programme].
Valerio L; Solsona L; Bentel FE; Baah TT; Ring D; Essuman P
Aten Primaria; 2006 Mar; 37(5):287-94. PubMed ID: 16595101
[TBL] [Abstract][Full Text] [Related]
8. Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.
Scott RK; Crochet S; Huang CC
Infect Dis Obstet Gynecol; 2018; 2018():6024698. PubMed ID: 29731602
[TBL] [Abstract][Full Text] [Related]
9. Rethinking mandatory HIV testing during pregnancy in areas with high HIV prevalence rates: ethical and policy issues.
Schuklenk U; Kleinsmidt A
Am J Public Health; 2007 Jul; 97(7):1179-83. PubMed ID: 17538051
[TBL] [Abstract][Full Text] [Related]
10. The lifetime medical cost savings from preventing HIV in the United States.
Schackman BR; Fleishman JA; Su AE; Berkowitz BK; Moore RD; Walensky RP; Becker JE; Voss C; Paltiel AD; Weinstein MC; Freedberg KA; Gebo KA; Losina E
Med Care; 2015 Apr; 53(4):293-301. PubMed ID: 25710311
[TBL] [Abstract][Full Text] [Related]
11. Estimating the impact of state budget cuts and redirection of prevention resources on the HIV epidemic in 59 California local health departments.
Lin F; Lasry A; Sansom SL; Wolitski RJ
PLoS One; 2013; 8(3):e55713. PubMed ID: 23520447
[TBL] [Abstract][Full Text] [Related]
12. Cost savings threshold analysis of a capacity-building program for HIV prevention organizations.
Dauner KN; Oglesby WH; Richter DL; LaRose CM; Holtgrave DR
AIDS Educ Prev; 2008 Jun; 20(3):265-74. PubMed ID: 18558823
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus infection in pregnancy.
Arikan Y; Burdge DR
Can J Infect Dis; 1998 Sep; 9(5):301-9. PubMed ID: 22346550
[TBL] [Abstract][Full Text] [Related]
14. Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings.
Bobić B; Villena I; Stillwaggon E
Food Waterborne Parasitol; 2019 Sep; 16():e00058. PubMed ID: 32095628
[TBL] [Abstract][Full Text] [Related]
15. Economic and health implications from earlier detection of HIV infection in the United Kingdom.
Zah V; Toumi M
HIV AIDS (Auckl); 2016; 8():67-74. PubMed ID: 27073328
[TBL] [Abstract][Full Text] [Related]
16. Mass Drug Administration: Contextual Factor Considerations.
Schneider ZD; Busbee AL; Boily MC; Shah MP; Hwang J; Lindblade KA; Gutman JR
Am J Trop Med Hyg; 2024 Apr; 110(4_Suppl):30-37. PubMed ID: 38266300
[TBL] [Abstract][Full Text] [Related]
17. The Economic Value of Treating Pediatric Obesity: Costs Are Not Keeping Up With Efficacy.
Ryder JR; Lim F; Hur C
JAMA Netw Open; 2023 Oct; 6(10):e2336337. PubMed ID: 37824149
[No Abstract] [Full Text] [Related]
18. Perinatal Antiretroviral Exposure and Prevented Mother-to-child HIV Infections in the Era of Antiretroviral Prophylaxis in the United States, 1994-2010.
Little KM; Taylor AW; Borkowf CB; Mendoza MC; Lampe MA; Weidle PJ; Nesheim SR
Pediatr Infect Dis J; 2017 Jan; 36(1):66-71. PubMed ID: 27749662
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.
Yu W; Li C; Fu X; Cui Z; Liu X; Fan L; Zhang G; Ma J
PLoS One; 2014; 9(7):e102872. PubMed ID: 25055039
[TBL] [Abstract][Full Text] [Related]
20. AIDS policy modeling for the 21st century: an overview of key issues.
Rauner MS; Brandeau ML
Health Care Manag Sci; 2001 Sep; 4(3):165-80. PubMed ID: 11519843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
